Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$99.8M |
| 2 |
Microsoft
MSFT
|
+$82.2M |
| 3 |
Pfizer
PFE
|
+$61.6M |
| 4 |
Colgate-Palmolive
CL
|
+$60M |
| 5 |
Amazon
AMZN
|
+$59.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DNY
DONNELLEY R R & SONS CO
DNY
|
+$64.4M |
| 2 |
Huntington Ingalls Industries
HII
|
+$51.6M |
| 3 |
Darden Restaurants
DRI
|
+$44.7M |
| 4 |
Lowe's Companies
LOW
|
+$40.5M |
| 5 |
LNKD
LinkedIn Corporation
LNKD
|
+$34.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.91% |
| 2 | Technology | 14.06% |
| 3 | Healthcare | 12.49% |
| 4 | Industrials | 11.09% |
| 5 | Consumer Discretionary | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RYZ
2226
Ryerson Holding Corp
RYZ
$1.42B
| $1.78M | ﹤0.01% |
132,965
+83,805
| +170% | +$1.03M |
|
|
ACHN
2227
DELISTED
Achillion Pharmaceuticals
ACHN
| $1.77M | ﹤0.01% |
428,841
-12,019
| -3% | -$63.9K |
|
2228
SiteOne Landscape Supply
SITE
$4.36B
| $1.77M | ﹤0.01% |
50,895
+16,271
| +47% | +$546K |
|
|
AFI
2229
DELISTED
Armstrong Flooring, Inc.
AFI
| $1.76M | ﹤0.01% |
88,360
+4,524
| +5% | +$83.3K |
|
2230
Glaukos
GKOS
$9.99B
| $1.75M | ﹤0.01% |
51,080
+1,540
| +3% | +$52.7K |
|
|
AHRT
2231
AH Realty Trust
AHRT
$518M
| $1.74M | ﹤0.01% |
119,597
+6,930
| +6% | +$96.1K |
|
|
BATS
2232
DELISTED
Bats Global Markets, Inc.
BATS
| $1.74M | ﹤0.01% |
51,963
+11,171
| +27% | +$351K |
|
2233
Biglari Holdings Class B
BH
$1.22B
| $1.74M | ﹤0.01% |
5,498
+231
| +4% | +$70K |
|
|
SHOR
2234
DELISTED
ShoreTel, Inc.
SHOR
| $1.73M | ﹤0.01% |
241,925
+13,014
| +6% | +$93.1K |
|
2235
Ternium
TX
$10.3B
| $1.73M | ﹤0.01% |
71,458
-4,723
| -6% | -$110K |
|
2236
ANI Pharmaceuticals
ANIP
$1.88B
| $1.72M | ﹤0.01% |
28,417
+1,540
| +6% | +$94.2K |
|
|
OTIC
2237
DELISTED
Otonomy, Inc.
OTIC
| $1.72M | ﹤0.01% |
107,988
+6,363
| +6% | +$107K |
|
2238
Valvoline
VVV
$4.61B
| $1.72M | ﹤0.01% |
+79,843
| New | +$1.69M |
|
2239
BioCryst Pharmaceuticals
BCRX
$2.4B
| $1.71M | ﹤0.01% |
270,581
+13,398
| +5% | +$69.7K |
|
2240
Greif Class B
GEF.B
$4.3B
| $1.71M | ﹤0.01% |
25,284
+1,694
| +7% | +$109K |
|
|
BNFT
2241
DELISTED
Benefitfocus, Inc.
BNFT
| $1.71M | ﹤0.01% |
57,452
+3,475
| +6% | +$111K |
|
2242
Citizens
CIA
$229M
| $1.7M | ﹤0.01% |
173,295
+7,854
| +5% | +$72.7K |
|
|
NILE
2243
DELISTED
Blue Nile, Inc.
NILE
| $1.7M | ﹤0.01% |
41,849
+2,185
| +6% | +$83.6K |
|
|
MACK
2244
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.7M | ﹤0.01% |
52,935
+2,564
| +5% | +$109K |
|
2245
Enanta Pharmaceuticals
ENTA
$385M
| $1.7M | ﹤0.01% |
50,576
+2,464
| +5% | +$70.6K |
|
|
VRTV
2246
DELISTED
VERITIV CORPORATION
VRTV
| $1.69M | ﹤0.01% |
31,434
+1,694
| +6% | +$87.8K |
|
2247
Medifast
MED
$137M
| $1.69M | ﹤0.01% |
40,520
+2,002
| +5% | +$80.6K |
|
|
AIMT
2248
DELISTED
Aimmune Therapeutics
AIMT
| $1.68M | ﹤0.01% |
82,269
+4,312
| +6% | +$88.1K |
|
|
ACTA
2249
DELISTED
Actua Corp
ACTA
| $1.68M | ﹤0.01% |
120,055
+5,698
| +5% | +$75.1K |
|
|
REV
2250
DELISTED
Revlon, Inc.
REV
| $1.68M | ﹤0.01% |
57,634
+3,013
| +6% | +$94.1K |
|
Similar funds
Charles Schwab's Q4 2016 Portfolio in Review
As of Q4 2016, Charles Schwab held 3,123 positions worth $91.3B, up 7.4% from $85.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $3.06B of net new capital in Q4 2016, opening 88 new positions and adding to 2,252 existing holdings. Its largest new stake was Howmet Aerospace: 1,721,382 shares worth $24.5M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Huntington Ingalls Industries, an estimated $51.6M trimmed.
- Charles Schwab's largest Q4 2016 buy was Howmet Aerospace: 1,721,382 shares worth $24.5M.
- Charles Schwab added most to Apple in Q4 2016, an estimated $99.8M increase.
- Charles Schwab's biggest Q4 2016 reduction was Huntington Ingalls Industries, cutting an estimated $51.6M.
- Charles Schwab fully exited DONNELLEY R R & SONS CO in Q4 2016, selling an estimated $64.4M.
- Charles Schwab's ten largest holdings make up 14% of its $91.3B portfolio in Q4 2016.
- Charles Schwab opened 88 new positions and closed 49 in Q4 2016.
- Charles Schwab's portfolio value rose 7.4% quarter-over-quarter to $91.3B.
Based on Charles Schwab's 13F filing for Q4 2016, filed 13 Feb 2017.